Prescient Therapeutics Ltd (PTX):企業の財務・戦略的SWOT分析

◆英語タイトル:Prescient Therapeutics Ltd (PTX) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH140529FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥84,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥126,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Prescient Therapeutics Ltd (Prescient Therapeutics), formerly Virax Holdings Ltd, is a biotechnology company which develops novel medicines for cancer treatment. The company is investigating OmniCAR, an immune receptor platform that controls T-cell activity and multi-antigen targeting with a single cell product for combined approach to formulate novel chimeric antigen receptor T (CAR-T) to treat cancer and other diseases. Its pipeline products include PTX-100, a compound which blocks geranylgeranyl transferase-1 (GGT-1), a cancer growth enzyme; and PTX-200, a novel PH domain inhibitor that obstructs protein kinase B or AKT signalling, which develops breast, ovarian cancer and leukemia. The company’s OmniCAR platform is built on technology licensed from University of Pennsylvania and SpyTag/SpyCatcher binding system licensed from Oxford University to develop improved CAR-T approaches for treating cancer and solid tumors. Prescient Therapeutics is headquartered in Melbourne, Victoria, Australia.

Prescient Therapeutics Ltd Key Recent Developments

Jan 18,2021: Prescient announces internal OmniCAR programs for three next-gen CAR-T therapies
Dec 17,2020: Leading International Blood Cancer Specialist Professor H. Miles Prince AM joins Prescient Scientific Advisory Board
Dec 09,2020: Prescient extending testing in COVID-19 antiviral screening program with Doherty Institute
Oct 20,2020: Prescient Therapeutics : September 2020 quarterly update and Appendix 4C
Oct 12,2020: Shedding Light on Prescient Therapeutics’ (PTX) personalised cancer treatments

This comprehensive SWOT profile of Prescient Therapeutics Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Prescient Therapeutics Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Prescient Therapeutics Ltd – Key Information
Prescient Therapeutics Ltd – Overview
Prescient Therapeutics Ltd – Key Employees
Prescient Therapeutics Ltd – Key Employee Biographies
Prescient Therapeutics Ltd – Key Operational Heads
Prescient Therapeutics Ltd – Major Products and Services
Prescient Therapeutics Ltd – History
Prescient Therapeutics Ltd – Company Statement
Prescient Therapeutics Ltd – Locations And Subsidiaries
Prescient Therapeutics Ltd
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Prescient Therapeutics Ltd – Business Description
Prescient Therapeutics Ltd – Corporate Strategy
Prescient Therapeutics Ltd – SWOT Analysis
SWOT Analysis – Overview
Prescient Therapeutics Ltd – Strengths
Prescient Therapeutics Ltd – Weaknesses
Prescient Therapeutics Ltd – Opportunities
Prescient Therapeutics Ltd – Threats
Prescient Therapeutics Ltd – Key Competitors

Section 3 – Company Financial Performance Charts

Prescient Therapeutics Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Prescient Therapeutics Ltd, Key Information
Prescient Therapeutics Ltd, Key Ratios
Prescient Therapeutics Ltd, Share Data
Prescient Therapeutics Ltd, Major Products and Services
Prescient Therapeutics Ltd, History
Prescient Therapeutics Ltd, Key Employees
Prescient Therapeutics Ltd, Key Employee Biographies
Prescient Therapeutics Ltd, Key Operational Heads
Prescient Therapeutics Ltd, Other Locations
Prescient Therapeutics Ltd, Subsidiaries
Prescient Therapeutics Ltd, Key Competitors
Prescient Therapeutics Ltd, SWOT Analysis
Prescient Therapeutics Ltd, Ratios based on current share price
Prescient Therapeutics Ltd, Annual Ratios
Prescient Therapeutics Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Prescient Therapeutics Ltd (PTX):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • High Peak Royalties Ltd (HPR):石油・ガス:M&Aディール及び事業提携情報
    Summary High Peak Royalties Limited (High Peak) is a leading utility company that builds a portfolio of diversified resource royalties with projects in exploration, pre-production and producing phases. It assesses a regular flow of potential royalty investments across the resources sector. The compa …
  • Engie Energia Chile SA (ECL):企業の財務・戦略的SWOT分析
    Engie Energia Chile SA (ECL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Knoll, Inc.:企業の戦略・SWOT・財務情報
    Knoll, Inc. - Strategy, SWOT and Corporate Finance Report Summary Knoll, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Skanray Technologies Pvt Ltd-医療機器分野:企業M&A・提携分析
    Summary Skanray Technologies Pvt Ltd (Skanray) is a medical equipment manufacturing company that provides high frequency x-ray imaging systems, critical care devices, and primary healthcare and telemedicine compatible devices. The company’s product categories include defibrillator, ventilators, surg …
  • Stryker Corp (SYK):企業の財務・戦略的SWOT分析
    Stryker Corp (SYK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Emera (Caribbean) Inc.:企業の戦略的SWOT分析
    Emera (Caribbean) Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Matinas BioPharma Holdings Inc (MTNB):製薬・医療:M&Aディール及び事業提携情報
    Summary Matinas BioPharma Holdings Inc (Matinas BioPharma) is a clinical-stage biopharmaceutical company that discovers and develops anti-infectives for orphan indications. The company develops lipid nano-crystal (LNC) technology, a drug delivery platform to deliver various molecules such as small m …
  • National Fuel Gas Company:企業の戦略・SWOT・財務情報
    National Fuel Gas Company - Strategy, SWOT and Corporate Finance Report Summary National Fuel Gas Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Steris Plc (STE):企業の財務・戦略的SWOT分析
    Steris Plc (STE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Siam Makro Public Company Limited (MAKRO):企業の財務・戦略的SWOT分析
    Siam Makro Public Company Limited (MAKRO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Hudson Pacific Properties Inc:企業のM&A・事業提携・投資動向
    Hudson Pacific Properties Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Hudson Pacific Properties Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Sheetz, Inc.:企業の戦略・SWOT・財務分析
    Sheetz, Inc. - Strategy, SWOT and Corporate Finance Report Summary Sheetz, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Wellcome Trust Sanger Institute:製薬・医療:M&Aディール及び事業提携情報
    Summary Wellcome Trust Sanger Institute (Sanger Institute) a subsidiary of Genome Research Ltd is a genomic discovery and research centre that carries out research and development in the areas of cellular and human genetics and infection genomics. It also provides postgraduate training on research a …
  • Bengal Energy Ltd (BNG):石油・ガス:M&Aディール及び事業提携情報
    Summary Bengal Energy Ltd (Bengal Energy), formerly Avery Resources Inc is an oil and gas exploration and production company that acquires, explores, and produces prospective light oil-weighted onshore assets in Australia’s Cooper Basin and India’s Cauvery Basin. The company holds interest in Toooko …
  • Osmotica Pharmaceutical Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Osmotica Pharmaceutical Corp (Osmotica) is a pharmaceutical company that specializes in drug delivery technologies and neurology based therapies. The company provides product portfolio such as nifedipine, oxybutynin, venlafaxine and desvenlafaxine, among others. It offers capabilities such a …
  • DCC Plc (DCC):石油・ガス:M&Aディール及び事業提携情報
    Summary DCC Plc (DCC) is a diversified company that offers international sales, marketing, distribution and business support services. The company operates through its business divisions such as LPG, retail, and oil, healthcare and technology. Its LPG business markets liquefied petroleum gas and nat …
  • BGR Energy Systems Ltd:企業の戦略・SWOT・財務情報
    BGR Energy Systems Ltd - Strategy, SWOT and Corporate Finance Report Summary BGR Energy Systems Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • InfuSystem Holdings Inc (INFU):企業の財務・戦略的SWOT分析
    Summary InfuSystem Holdings Inc (InfuSystem) is a provider of infusion pumps and related services. The company provides ambulatory infusion pumps and associated clinical services. Its patient services comprise infucare help hotline, infuease, education, and pain management. InfuSystem offers pumps a …
  • Lietuvos energijos gamyba, AB (LNR1L):企業の財務・戦略的SWOT分析
    Lietuvos energijos gamyba, AB (LNR1L) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Drax Group Plc (DRX)-エネルギー分野:企業M&A・提携分析
    Summary Drax Group plc (Drax) is a biomass-fuelled electricity generator, which generates electricity from coal and biomass. It operates across three principal areas of activity, electricity generation; electricity sales to business customers; and compressed wood pellet production. The company opera …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆